News USAID site offline as Musk says it should be shut down The future of USAID, the world's largest donor of humanitarian aid, is in doubt as Trump claims it is run by "a bunch of radical lunatics."
News Sickle cell gene therapy Casgevy finally cleared for NHS use Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after an earlier rejection.
News Rad AI raises $60m, and other digital financings Recent financings in the digital health and AI space include rounds for Rad AI, Eleos, Allara Health, Manas AI, Delfina Care, and Grey Matter Neuro.
News Could an ECG spot people at risk of cognitive decline? UK Biobank study suggests someone's risk of premature ageing or cognitive decline could be predicted using a simple ECG reading supported by an AI.
News Dust mite allergy sufferers set for a new NHS treatment ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales and Northern Ireland, but not in Scotland.
News Vaccines dominate questioning at RFK Jr's first hearing Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior anti-vaccine stance.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.